name: Sutures, Synthetic, Absorbable, Polyhydroxybutyrate, Monofilament


name: Sutures, Synthetic, Absorbable, Polyhydroxybutyrate, Multifilament


name: IVD Test Reagent/Kits, Immunoassay, Tumor Marker, Breast Cancer


name: IVD Panels, Human Genetics, Eye Disorder, MAC Spectrum


name: IVD Panels, Human Genetics, Proportionate Short Stature


name: IVD Test Reagent/Kits, Multimodal Assay, Chromosome Anomaly/Gene Anomaly/Microsatellite Instability


name: IVD Test Reagent/Kits, Multimodal Assay, DNA Methylation/Gene Anomaly


name: In Vitro Diagnostics and Laboratory Equipment


name: Analyzers, Point-of-Care, Whole Blood, Creatinine


name: ENSULIZOLE 20 mg in 1 mL / OCTINOXATE 55 mg in 1 mL / OXYBENZONE 5 mg in 1 mL / TITANIUM DIOXIDE 84 mg in 1 mL / ZINC OXIDE 98 mg in 1 mL TOPICAL CREAM [Artistry Ideal Radiance Illuminating CC SPF 50 Broad Spectrum Med/Deep]


name: OCTINOXATE 40 mg in 1 mL / ZINC OXIDE 27.4 mg in 1 mL TOPICAL CREAM [Artistry Hydro-V Sheer Weightless Foundation SPF 15 Broad Spectrum Sunscreen]


name: Witch Hazel 0.25 g in 5 mL TOPICAL LIQUID [Roseday Rose]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 18.2 g in 100 g TOPICAL STICK [Axe Black Antiperspirant and Deodorant]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 80 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 40 mg in 1 mL / OXYBENZONE 40 mg in 1 mL TOPICAL CREAM [Sheer Touch Sunscreen]


name: Avobenzone 26.07 mg in 1 g / Homosalate 86.9 mg in 1 g / Octisalate 43.45 mg in 1 g / Octocrylene 34.76 mg in 1 g / OXYBENZONE 43.45 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: Avobenzone 30.9 mg in 1 g / Homosalate 133.9 mg in 1 g / Octisalate 51.5 mg in 1 g / OCTOCRYLENE 72.1 mg in 1 g / Oxybenzone 41.2 mg in 1 g TOPICAL SPRAY [Sunscreen]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Axe Advanced Protection Antiperspirant and Deodorant]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 28 mg in 1 mL / OXYBENZONE 60 mg in 1 mL TOPICAL CREAM [Sheer Touch Sunscreen]


name: Octinoxate 4.0 g in 50 g / Titanium Dioxide 1.5 g in 50 g / Octisalate 1.0 g in 50 g TOPICAL CREAM [Dr MEDECEAN Rising Sun Cover]


name: Niacinamide 1.0 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [CRE AM2ATE Knight Seahorse]


name: NIACINAMIDE 1.75 g in 25 mL / ALLANTOIN 0.075 g in 25 mL TOPICAL PATCH [EMP COLLAGEN BOOST]


name: Niacinamide 2.0 g in 100 mL / Adenosine 0.04 g in 100 mL TOPICAL SPRAY [RUBELLI WATER GLOW ESSENCE]


name: PANTHENOL 0.162 g in 27 mL / ALLANTOIN 0.081 g in 27 mL TOPICAL PATCH [MICRO DUST DETOX]


name: Dimethicone 1.2 g in 40 g / Allantoin 0.2 g in 40 g TOPICAL LIQUID [Dr MEDECEAN Return Whitening Essence]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 11.4 g in 100 g TOPICAL STICK [Axe Forest Antiperspirant and Deodorant]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19 g in 100 g TOPICAL STICK [Axe Charge Up Antiperspirant and Deodorant]


name: AVOBENZONE 30 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 30 mg in 1 mL / OXYBENZONE 50 mg in 1 mL TOPICAL LOTION [LEDERM DAY SUNSCREEN BROAD SPECTRUM SPF 15 day facial SPF 15 against noticeable signs of aging all skin types]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-3.4%-3.4%-4.7% Topical application Lotion


name: Ensulizole/Octinoxate/Octisalate/Titanium Dioxide/Zinc Oxide 2%-7.5%-4.5%-2.4%-4.8% Topical application Lotion


name: Octinoxate/Octisalate/Oxybenzone 7.5%-3%-3% Topical application Lotion


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-3%-4%-9% Topical application Cream


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-3.5%-3.5%-4.5% Topical application Lotion


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-5%-5%-9% Topical application Cream


name: Nutritional Supplement Oral Packet [SIMILAC GO & GROW MIX-INS]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19.2 g in 100 g TOPICAL STICK [Degree Men MotionSense Cool Rush 48H Antiperspirant]


name: AVOBENZONE 15 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / OCTISALATE 40 mg in 1 mL / OCTOCRYLENE 60 mg in 1 mL TOPICAL LOTION [Neutrogena HydroBoost Water Gel Sunscreen Broad Spectrum SPF 30]


name: Octinoxate 75 mg in 1 mL / Octisalate 50 mg in 1 mL / Oxybenzone 60 mg in 1 mL TOPICAL LOTION [Sunscreen with Aloe Vera SPF 30]


name: octinoxate 55 mg in 1 mL / Avobenzone 25 mg in 1 mL / octocrylene 20 mg in 1 mL TOPICAL LOTION [Tiege Hanley AM Morning Facial Moisturizer with SPF20]


name: Multi Vitamin+, Multiple Vitamins oral liquid


name: lanolin / menthol / petrolatum / zinc oxide


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-3.4%-3.4%-4.7% Topical application Lotion [EUCERIN DAILY HYDRATION MOISTURIZER & SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-3.5%-3.5%-4.5% Topical application Lotion [EUCERIN REDNESS RELIEF]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-3%-4%-9% Topical application Cream [EUCERIN DAILY HYDRATION MOISTURIZER & SUNSCREEN]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 3%-5%-5%-9% Topical application Cream [EUCERIN DAILY HYDRATION MOISTURIZER & SUNSCREEN]


name: Avobenzone/Octinoxate/Octisalate/Octocrylene/Oxybenzone/Petrolatum 3%-6.75%-4.5%-2%-5.4%-31% Topical application Ointment [AQUAPHOR LIP PROTECTANT+SUNSCREEN]


name: Eucerin Skin Calming Body Wash, topical soap


name: Cream, Multi Ingredient Topical application Cream [EUCERIN ADVANCED REPAIR]


name: Cream, Multi Ingredient Topical application Cream [EUCERIN BABY]


name: Cream, Multi Ingredient Topical application Cream [EUCERIN Q10 ANTI-WRINKLE]


name: Cream, Multi Ingredient Topical application Cream [EUCERIN REDNESS RELIEF]


name: Cream, Multi Ingredient Topical application Cream [EUCERIN SKIN CALMING]


name: Ensulizole/Octinoxate/Octisalate/Titanium Dioxide/Zinc Oxide 2%-7.5%-4.5%-2.4%-4.8% Topical application Lotion [EUCERIN DAILY PROTECTION]


name: Gel, Multi Ingredient Topical application Gel/Jelly [EUCERIN REDNESS RELIEF]


name: Gel, Multi Ingredient Topical application Gel/Jelly [TUGABOOS BABY OIL]


name: Gel, Multi Ingredient;Gel, Multi Ingredient NA; NA Topical application Gel/Jelly


name: Gel, Multi Ingredient;Gel, Multi Ingredient NA; NA Topical application Gel/Jelly [INTIMACY GELS FOR HIM AND HER]


name: Lotion, Multi Ingredient Topical application Lotion [EUCERIN BABY]


name: Lotion, Multi Ingredient Topical application Lotion [EUCERIN DAILY HYDRATION]


name: Lotion, Multi Ingredient Topical application Lotion [EUCERIN IN-SHOWER MOISTURIZER]


name: Lotion, Multi Ingredient Topical application Lotion [EUCERIN INTENSIVE REPAIR]


name: Lotion, Multi Ingredient Topical application Lotion [EUCERIN ORIGINAL HEALING]


name: Lotion, Multi Ingredient Topical application Lotion [EUCERIN PROFESSIONAL REPAIR]


name: Lotion, Multi Ingredient Topical application Lotion [EUCERIN SKIN CALMING]


name: Octinoxate/Octisalate/Oxybenzone 7.5%-3%-3% Topical application Lotion [EUCERIN Q10 ANTI-WRINKLE]


name: Ointment, Multi Ingredient Topical application Ointment [AQUAPHOR LIP REPAIR]


name: Powder, Multi Ingredient Topical application Powder [TUGABOOS LAVENDER & CHAMOMILE BABY POWDER]


name: Shampoo, Multi Ingredient Topical application Shampoo [AQUAPHOR CLEANSING BABY WASH & SHAMPOO]


name: Shampoo, Multi Ingredient Topical application Shampoo [EUCERIN BABY WASH & SHAMPOO]


name: AVOBENZONE 30 mg in 1 mL / HOMOSALATE 100 mg in 1 mL / OCTISALATE 50 mg in 1 mL / OCTOCRYLENE 100 mg in 1 mL TOPICAL CREAM [Sun Bum Face 50 Sunscreen]


name: kit for prep Tc-99m/exametazime 0.5 mg INTRAVEN VIAL (EA)


name: arginine oxoglurate 350 mg ORAL TABLET, EXTENDED RELEASE


name: Leader LE1 Blood Glucose Monitoring System


name: influenza A virus A/New Caledonia/71/2014 (H3N2) antigen / influenza A virus A/Slovenia/2903/2015 (H1N1) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen


name: OCTINOXATE 7.5 mg in 1 g / OXYBENZONE 5.0 mg in 1 g / OCTOCRYLENE 10.0 mg in 1 g / OCTISALATE 5.0 mg in 1 g TOPICAL STICK [ChapIce SPF 30 Lip Balm]


name: Octinoxate 0.075 g in 1 g TOPICAL LIPSTICK [ESIKA PRO PERFECT MATCH VOLUMEN (BURGUNDY VITAL) - RED]


name: ZINC OXIDE 200 mg in 1 mL TOPICAL CREAM [Baby Bum SPF50 Mineral Sunscreen]


name: Acetaminophen/Dextromethorphan Hydrobromide/Guaifenesin/Phenylephrine Hydrochloride;Acetaminophen/Diphenhydramine Hydrochloride/Phenylephrine Hydrochloride 650 MG/20 ML-20 MG/20 ML-400 MG/20 ML-10 MG/20 ML; 650 MG/20 ML-25 MG/20 ML-10 MG/20 ML Oral Solution


name: ZINC OXIDE 0.13 mg in 2.5 mL TOPICAL LOTION [Pharmaskincare Solar-C Moisturizer SPF 15]


name: Multivitamin Oral Tablet [DAILY MULTIVITAMIN]


name: Mouthwash Oromucosal Solution [ORAL CARE DRY MOUTH MOUTHWASH]


name: NORGESTREL 0.3 mg / ETHINYL ESTRADIOL 0.03 mg ORAL TABLET [Elinest]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19.2 g in 100 g TOPICAL STICK [Degree Men MotionSense Everest 48H Antiperspirant]


name: Esomeprazole Magnesium;Ibuprofen;Lidocaine/Menthol 40 MG; 100 MG/5 ML; 4%-1% Multiple Routes Kit [ANODYNE ILE]


name: ALUMINUM CHLOROHYDRATE 14 g in 100 mL TOPICAL LIQUID [Secret Roll-On Powder Fresh]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 18.2 g in 100 g TOPICAL STICK [Degree Men Cool Rush 48H Antiperspirant]


name: AVOBENZONE 2.25 g in 75 g / OCTINOXATE 0.375 g in 75 g / OCTISALATE 3.75 g in 75 g / OCTOCRYLENE 5.625 g in 75 g TOPICAL CREAM [YourGoodSkin SPF 30 Anti-oxidant Day Sunscreen Broad Spectrum SPF 30]


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 8 g in 100 mL / OCTINOXATE 4.5 g in 100 mL / OCTISALATE 5 g in 100 mL TOPICAL CREAM [Unseen Sunscreen Broad Spectrum SPF 40]


name: DIMETHICONE 2 g in 100 g TOPICAL JELLY [Berry Powerful Lip Care]


name: TITANIUM DIOXIDE 0.2625 mg in 2.5 mL TOPICAL LOTION [Pharmaskincare Solar-C Moisturizer SPF 30]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 18.2 g in 100 g TOPICAL STICK [Degree Men Sport 48H Antiperspirant]


name: ZINC OXIDE 0.238 mg in 2.5 mL / OCTINOXATE 0.188 mg in 2.5 mL TOPICAL LOTION [Pharmaskincare Solar-C Moisturizer SPF 50]


name: Titanium Dioxide 1.15 g in 12 g / Octinoxate 0.80 g in 12 g / Octisalate 0.48 g in 12 g TOPICAL POWDER [Microfit Cushion 101]


name: Titanium Dioxide 1.31 g in 10 g / Octinoxate 0.67 g in 10 g / Octisalate 0.40 g in 10 g TOPICAL POWDER [PRPL dual cover cushion No 21 cre am ivory Cushion]


name: DIMETHICONE 1 g in 100 g / MERADIMATE 5 g in 100 g / OCTINOXATE 7.5 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 6 g in 100 g TOPICAL STICK [Herpecin L]


name: Octinoxate 0.84 g in 12 g / Titanium Dioxide 0.71 g in 12 g / Zinc Oxide 0.58 g in 12 g / Octisalate 0.54 g in 12 g TOPICAL POWDER [Moonflash Cushion]


name: Octinoxate 3.5 g in 50 mL / Octocrylene 2.5 g in 50 mL / Octisalate 2.25 g in 50 mL TOPICAL CREAM [Multi Protection UV Bouncer]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19.2 g in 100 g TOPICAL STICK [Degree Men MotionSense Adventure 48H Antiperspirant]


name: TITANIUM DIOXIDE 5.6 g in 100 mL TOPICAL LIQUID [Rosilliance Medium/Dark SPF 30 Broad Spectrum]


name: Titanium Dioxide 1.43 g in 6 g TOPICAL POWDER [PRPL dual cover cushion No 21 cre am ivory Conceal Balm]


name: Niacinamide 0.02 g in 23 g / Adenosine 0.002 g in 23 g TOPICAL PATCH [MULBIT Collagen Mask Pack]


name: ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY 19.2 g in 100 g TOPICAL STICK [Degree Men MotionSense Active Shield 48H Antiperspirant]


name: AVOBENZONE 29 mg in 1 mL / HOMOSALATE 90 mg in 1 mL / OCTINOXATE 68 mg in 1 mL / OCTISALATE 45 mg in 1 mL / OCTOCRYLENE 50 mg in 1 mL TOPICAL LOTION [Aegis Daily Facial SPF 25]


name: Glycerin 0.34 g in 17 g TOPICAL PATCH [Man Power Pack]


name: Niacinamide 1.0 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [MULBIT Donkey Milk Moisturizing]


name: Niacinamide 0.54 g in 27 mL / Adenosine 0.01 g in 27 mL TOPICAL LIQUID [MULBIT Hydro Special Ample]


name: Niacinamide 0.54 g in 27 g / Adenosine 0.01 g in 27 g TOPICAL PATCH [MULBIT Donkey Milk Mask]


name: Niacinamide 0.02 g in 23 g / Adenosine 0.002 g in 23 g TOPICAL PATCH [MULBIT Aqua Mask Pack]


name: Aluminum Sesquichlorohydrate 0.15048 kg in 1 kg TOPICAL Lotion [Carpe Antiperspirant for Feet]


name: TITANIUM DIOXIDE 100 mg in 1 mL / ZINC OXIDE 100 mg in 1 mL TOPICAL CREAM [Broad Spectrum SPF 50 Mineral Sunscreen]


name: TITANIUM DIOXIDE 80 mg in 1 mL / ZINC OXIDE 100 mg in 1 mL TOPICAL CREAM [Broad Spectrum SPF 30 Mineral Sunscreen]


name: Niacinamide 0.08 g in 81 g / Adenosine 0.008 g in 81 g TOPICAL LIQUID [MULBIT MEDIST]


name: Food Starch, Modified/Maltodextrin Oral Powder


name: NORETHINDRONE ACETATE 1.5 mg / ETHINYL ESTRADIOL 30 ug ORAL TABLET [AUROVELA Fe]


name: {21 (ethinyl estradiol 0.03 MG / norethindrone acetate 1.5 MG Oral Tablet) / 7 (ferrous fumarate 75 MG Oral Tablet) } Pack [Aurovela Fe 1.5/30 28 Day]


name: OCTINOXATE 2.4 mg in 40 mL / OCTISALATE 1.2 mg in 40 mL / TITANIUM DIOXIDE 0.49 mg in 40 mL TOPICAL CREAM [Sun Project Shimmer Sun Essence]


name: OCTINOXATE 2.4 mg in 40 mL / TITANIUM DIOXIDE 1.61 mg in 40 mL / OCTISALATE 0.8 mg in 40 mL / ZINC OXIDE 0.77 mg in 40 mL TOPICAL CREAM [Be Beautiful Makeup Base]


name: OCTOCRYLENE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL SPRAY [Reef Babies SPF 50 Oxybenzone Free]


name: In Control Micro Thin Unilet Lancets 33g


name: In Control Super Thin Unilet Lancets 30g


name: ALUMINUM HYDROXIDE 200 mg / MAGNESIUM HYDROXIDE 200 mg / DIMETHICONE 21 mg ORAL TABLET, CHEWABLE [MAGSIL ANTACID (LEMON MINT)]


name: capsaicin / lidocaine / trolamine salicylate


name: OCTINOXATE 55 mg in 1 mL / AVOBENZONE 30 mg in 1 mL / OCTOCRYLENE 20 mg in 1 mL TOPICAL CREAM [No BS SPF20 Moisturizer]


name: TITANIUM DIOXIDE 1.26 g in 50 mL TOPICAL CREAM [Sunscreen 100]


name: flash glucose scanning reader MISCELL EACH


name: vaccine adjuvant system, AS01B/PF, component vial 1 of 2 INTRAMUSC VIAL (ML)


name: syringe cap, ENFit,non-sterile MISCELL EACH


name: syringe, ENFit 1 mL, non-sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 1 mL, sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 12 mL, non-sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 12 mL, sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 3 mL, sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 35 mL, non-sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 35 mL, sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 6 mL, non-sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 6 mL, sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 60 mL, non-sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe, ENFit 60 mL, sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,ENFit 3 mL,non-sterile MISCELL SYRINGE, EMPTY DISPOSABLE


name: Homosalate 2.5 g in 50 mL / Octinoxate 2.5 in 50 mL / Zinc Oxide 2 g in 50 mL / Titanium Dioxide 1.45 g in 50 mL TOPICAL CREAM [Powerproof Sunscreen 100]


name: cardioplegic solution no.21 (reperfusate 4:1)


name: cardioplegic solution no.20 (maintenance 4:1)


name: cardioplegic solution no.22 (induction 4:1)


name: magnesium glycinate, chloride, citrate, sulfate


name: mvi, adult no.1 with vitamin K, component 1 of 2


name: mvi, adult no.1 with vitamin K, component 2 of 2


name: lemon eucalyptus oil 25 % TOPICAL SPRAY, NON-AEROSOL (ML)


name: Diclofenac Sodium;Menthol/Methyl Salicylate 1%; 10%-30% Multiple Routes Kit [DICLOPR]


name: OCTINOXATE 1.8 g in 30 mL / Titanium Dioxide 1.2132 g in 30 mL / OCTISALATE 0.6 g in 30 mL / Zinc Oxide 0.576 g in 30 mL TOPICAL CREAM [Intensive Cover Blemish Balm]


name: OCTINOXATE 81.75 mg in 1 mL / OCTISALATE 43.6 mg in 1 mL / OXYBENZONE 27.25 mg in 1 mL / TITANIUM DIOXIDE 11.99 mg in 1 mL TOPICAL CREAM [MAC LIGHTFUL Cplus CORAL GRASS TINTED WITH RADIANCE BOOSTER BROAD SPECTRUM SPF030]


name: Octinoxate 30 mg in 1 mL TOPICAL LIQUID [Lancome Paris Skin Feels Good Broad Spectrum SPF 23 Sunscreen Hydrating Skin Tint Healthy Glow]


name: Titanium Dioxide 2.40 g in 30 mL / Octinoxate 2.25 g in 30 mL TOPICAL CREAM [Dr Young Protect Prevent Triple Action BB]


name: Titanium Dioxide 2.67 g in 30 mL / Octinoxate 1.95 g in 30 mL / Zinc Oxide 0.27 g in 30 mL TOPICAL CREAM [Dr Young Protect Prevent 2P Blemish Base]


name: Titanium Dioxide 2.67 g in 30 mL / Octinoxate 1.95 g in 30 mL / Zinc Oxide 0.27 g in 30 mL TOPICAL CREAM [Dr Young Protect Prevent 2P Pearl Brightening Balm]


name: Avobenzone 30 mg in 1 mL / HOMOSALATE 50 mg in 1 mL / Octisalate 50 mg in 1 mL / Octocrylene 70 mg in 1 mL TOPICAL LOTION [Lancome Paris Renergie Lift MultiAction Ultra Firming and Dark Spot Correcting Moisturizer Broad Spectrum SPF 30 Sunscreen]


name: OCTOCRYLENE 5 g in 100 mL / OCTISALATE 3 g in 100 mL / AVOBENZONE 2.5 g in 100 mL TOPICAL SPRAY [Reef Kids SPF 30 Oxybenzone Free]


name: OCTOCRYLENE 10 g in 100 mL / OCTISALATE 5 g in 100 mL / AVOBENZONE 3 g in 100 mL TOPICAL LOTION [Reef Babies SPF 50 Oxybenzone Free]


name: OCTOCRYLENE 5 g in 100 mL / OCTISALATE 3 g in 100 mL / AVOBENZONE 2.5 g in 100 mL TOPICAL LOTION [Reef Kids SPF 30 Oxybenzone Free]


name: BAG,AEROSOL DRAINAGE WITH Y CONNECTOR #HCS974Y


name: CATHERIZATION SET,INTERMITTENT,CLOSED 12FR MTG #42112


name: CATHETER,CLEAN-CATH VINYL 16FR BARD#423716


name: CATHETER,INTERMITTENT 14FR COLOPLAST #28914


name: CATHETER,INTERMITTENT 16FR COLOPLAST #28416


name: CATHETER,INTERMITTENT COUDE 16FR COLOPLAST #28496


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 14FR RUSCH #MMG-ONC-14C


name: CATHETER,SUCTION,12FR KIT CAREFUSION #4868T


name: CATHETER,SUCTION,14FR KIT CAREFUSION #44-14


name: CATHETER,SUCTION,14FR KIT CAREFUSION #T160C


name: CONNECTOR,LOW VOLUME,ENFIT MOOG INFINITY


name: DRESSING,ALGISITE M CALCIUM ALGINATE 4IN X 4IN #59480200


name: DRESSING,OPSITE IV3000 FRAME 4IN X 4 3/4 SN#59410882


name: DRESSING,OPTIFOAM GENTLE BORDER 3IN X 3IN #MSC2033


name: DRESSING,OPTIFOAM THIN ADHESIVE 4IN X 4IN #MSC1544


name: DRESSING,TEGADERM,FOAM 7-1/2IN X 8-3/4IN 3M#90616


name: TRANSPARENT DRESSING IV3000 4IN X 5.5IN SN#4925


name: Ethinyl Estradiol-Norethind and Ferro Fuma


name: Niacinamide 1.00 g in 50 mL / Adenosine 0.02 g in 50 mL TOPICAL CREAM [MULBIT ME FIRMING SLEEPING PACK]


name: LARYNGECTOMY TUBE BRUSH,12MM PROVOX #7661


name: Allantoin 0.007 g in 0.7 g TOPICAL POWDER [RAPHAGEN POWDE R]


name: CAPSICUM ANNUUM WHOLE 0.05 g in 100 g TOPICAL PATCH [SpaGelpatch 42degrees celsius CORSET]


name: TITANIUM DIOXIDE 60 mg in 1 mL / ZINC OXIDE 60 mg in 1 mL TOPICAL CREAM [koa protect our ocean life OXYBENZONE FREE Broad Spectrum SPF 30 UVA UVB Protection Sunscreen]


name: ALUMINUM CHLOROHYDRATE 22 g in 100 mL TOPICAL LIQUID [Dove]


name: Adenosine 0.01 g in 50 mL TOPICAL CREAM [ARMIYOU HYDROGEN SERUM]


name: Adenosine 0.04 g in 120 mL TOPICAL EMULSION [ARMIYOU HYDROGEN]


name: Adenosine 0.04 g in 120 mL TOPICAL LIQUID [ARMIYOU HYDROGEN TONER]


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Tablet) / 4 (ferrous fumarate 75 MG Oral Tablet) } Pack [Hailey 24 Fe 28 Day]


name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [Endless Love For Men]


name: ILEX PARAGUARIENSIS LEAF 3.0 g in 150 mL TOPICAL CREAM [LeBody Fit Body Massager]


name: Guidance for percutaneous aspiration.fine needle


name: Number of pressure injuries - unstageable due to coverage of wound bed by slough &or eschar


name: Number of pressure injuries present upon admission &or reentry - unstageable due to coverage of wound bed by slough &or eschar


name: Number of pressure injuries present upon admission &or reentry - stage 2


name: Number of pressure injuries present upon admission &or reentry - stage 3


name: Number of pressure injuries present upon admission &or reentry - stage 4


name: Number of pressure injuries - unstageable due to non-removable dressing or device


name: Number of pressure injuries present upon admission &or reentry - unstageable due to non-removable dressing


name: Number of pressure injuries - unstageable with suspected deep tissue injury in evolution


name: Number of pressure injuries present upon admission &or reentry - unstageable with suspected deep tissue injury in evolution


name: Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 2


name: Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 3


name: Number of current pressure injuries not present or were at a lesser stage on prior assessment - stage 4


name: Number of pressure injuries noted on prior assessment that have completely closed - stage 2


name: Number of pressure injuries noted on prior assessment that have completely closed - stage 3


name: Number of pressure injuries noted on prior assessment that have completely closed - stage 4


name: Plan of care includes intervention to prevent pressure injuries


name: Plan of care includes pressure injury treatment - moist healing


name: Breaths:NRat:Pt:Respiratory system:Qn:Non-airway pressure measurement


name: High pressure hold time setting:Time:Pt:Ventilator:Qn


name: High pressure hold time:Time:Pt:Ventilator:Qn


name: Inflation trigger flow setting:VRat:Pt:Ventilator:Qn


name: Inflation trigger pressure setting:Pres:Pt:Ventilator:Qn


name: Inspiratory pause time setting:Time:Pt:Ventilator:Qn


name: Low pressure hold time:Time:Pt:Ventilator:Qn


name: Low pressure hold time setting:Time:Pt:Ventilator:Qn


name: Positive pressure phase duration:Time:Pt:Ventilator:Qn


name: Inspiratory gas flow:VRat:Pt:Respiratory system.airway:Qn


name: Current number of unhealed pressure injuries at each stage - admission


name: Current number of unhealed pressure injuries at each stage - discharge


name: Number of pressure injuries noted on prior assessment that have completely closed - stage 1


name: JAK2 gene.p.Val617Phe mutant/normal:RelRto:Pt:Bone mar:Qn:Molgen


name: Medication management note:Find:Pt:Patient's home:Doc:{Role}


name: Underlying resolved condition.multiple coding ICD code:Prid:RptPeriod:^Patient:Nom:CMS Assessment


name: Patient history and diagnoses - transfer or discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: Clinical record items - transfer or discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2, D - Medications - transfer to inpatient facility:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2, D - Medications - transfer to inpatient facility


name: When anxious within the last 14D:Find:14D:^Patient:Ord:CMS Assessment


name: Consultation note:Find:Pt:{Setting}:Doc:Clinical cardiac electrophysiology


name: Counseling note:Find:Pt:{Setting}:Doc:Physical medicine and rehab


name: Home health patient tracking sheet - resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: Home health patient tracking sheet - resumption of care


name: Outcome and assessment information set (OASIS) form - version C2 - Start of care


name: Home health patient tracking sheet - start of care:-:RptPeriod:^Patient:-:CMS Assessment


name: Home health patient tracking sheet - start of care


name: OASIS C2 - Patient history and diagnoses - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Patient history and diagnoses - start of care or resumption of care


name: Diagnoses, symptom control, and optional diagnoses:-:RptPeriod:^Patient:-:CMS Assessment


name: Underlying resolved condition ICD code:Prid:RptPeriod:^Patient:Nom:CMS Assessment


name: Episode of care includes influenza vaccination season:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: OASIS C2 - Integumentary status - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Integumentary status - start of care or resumption of care


name: Unhealed pressure injury at stage 2 or higher or designated as unstageable:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: OASIS C2 - Current number of unhealed pressure injuries at each stage - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Current number of unhealed pressure injuries at each stage - start of care or resumption of care


name: Symptom control rating:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: OASIS C2 - Respiratory status - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Respiratory status - start of care or resumption of care


name: OASIS C2 - Elimination status - start of care or resumption of care:-:-:^Patient:-:CMS Assessment


name: OASIS C2 - Elimination status - start of care or resumption of care


name: OASIS C2 - ADL and IADLs - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - ADL and IADLs - start of care or resumption of care


name: OASIS C2 - Functional abilities and goals - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Functional abilities and goals - start of care or resumption of care


name: OASIS C2 - Mobility:-:RptPeriod:^Patient:-:CMS Assessment


name: Lying to sitting on side of bed - functional ability:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Lying to sitting on side of bed - functional goal:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: OASIS C2 - Medications - start of care or resumption of care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Medications - start of care or resumption of care


name: Living situation and availability of assistance:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Nursing home comprehensive (NC) item set


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information


name: Type of assessment:-:RptPeriod:^Patient:-:CMS Assessment


name: SNF Part A PPS discharge assessment:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Unit certification or licensure designation:Type:RptPeriod:Facility:Nom:CMS Assessment


name: Unit certification or licensure designation


name: Prior functioning.household tasks:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version C2 - Resumption of care


name: Outcome and assessment information set (OASIS) form - version C2 - Follow-up - recertification or other follow-up


name: OASIS E - Administrative Information - FU:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS E - Administrative Information - FU


name: OASIS C2 - Patient history and diagnoses - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Patient history and diagnoses - follow-up


name: Sensory status - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Integumentary status - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Integumentary status - follow-up


name: OASIS C2, D - Respiratory status - follow-up or discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2, D - Respiratory status - follow-up or discharge


name: OASIS C2, D - Elimination status - follow-up:-:-:^Patient:-:CMS Assessment


name: OASIS C2, D - Elimination status - follow-up


name: OASIS C2, D - ADL and IADLs - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2, D - Medications - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Therapy need and plan of care - follow-up:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version C2 - Transfer to inpatient facility - patient discharged or not discharged


name: Data items collected at inpatient facility admission or agency discharge only - transfer:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version C2 - Discharged from agency - death at home


name: OASIS E - Medications - TRN:-:RptPeriod:^Patient:-:CMS Assessment


name: Data items collected at inpatient facility admission or agency discharge only - discharge from agency - death at home:-:RptPeriod:^Patient:-:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version C2 - Discharged from agency


name: OASIS C2 - Medications - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Medications - discharge from agency


name: Sensory status - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Integumentary status - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Integumentary status - discharge from agency


name: Worsening in pressure injury status since start or resumption of home care:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Elimination status - discharge from agency:-:RptPeriod:^Patient:-:CMS Assessment


name: OASIS C2 - Elimination status - discharge from agency


name: Current number of unhealed pressure injuries at each stage - follow-up or discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: Conditions prior to medical or treatment regimen change or inpatient stay that took place within past 14D:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Most recent inpatient discharge date in the last 14D:Date:14D:^Patient:Qn:CMS Assessment


name: Most recent inpatient discharge date in the last 14D


name: Ostomy for bowel elimination in the last 14D:Find:14D:^Patient:Ord:CMS Assessment


name: Ostomy for bowel elimination in the last 14D


name: Minimum Data Set (MDS) - version 3.0 - Resident Assessment Instrument (RAI) version 1.14.1


name: Conditions related to intellectual disability and developmental disability status:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Most recent admission &or entry or reentry into this facility:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Cognitive patterns:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Current number of unhealed pressure injuries at each stage:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Current number of unhealed pressure injuries at each stage


name: Dimensions of unhealed stage 3 or 4 pressure injuries or eschar:-:RptPeriod:^Patient:-:CMS Assessment


name: Skin and pressure injury &or injury treatments during assessment period:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Number of D antipsychotic received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D antipsychotic received in last 7D or since admission &or reentry if less than 7D


name: Number of D antianxiety received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D antianxiety received in last 7D or since admission &or reentry if less than 7D


name: Number of D antidepressant received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D antidepressant received in last 7D or since admission &or reentry if less than 7D


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - ND, SD


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NOD, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NOD, SOD


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - SP


name: MDS v3.0 - RAI v1.17.2 - Therapies - NP, NQ:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Therapies - NS, NSD, SS, SSD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Therapies - NS, NSD, SS, SSD


name: Resident mood interview (PHQ-9) - symptom presence in the last 2W:-:2W:^Patient:-:CMS Assessment


name: Resident mood interview (PHQ-9) - symptom presence in the last 2W


name: Resident mood interview (PHQ-9) - symptom frequency in the last 2W:-:2W:^Patient:-:CMS Assessment


name: Resident mood interview (PHQ-9) - symptom frequency in the last 2W


name: MDS v3.0 - RAI v1.17.2 - Therapies - ND:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Therapies - NOD, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Therapies - SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Occupational therapy - ND:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Respiratory therapy - NP, NQ, SP, IPA, OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Psychological therapy - NP, NQ:-:RptPeriod:^Patient:-:CMS Assessment


name: Invasive mechanical ventilator liberation status at discharge:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Guidance for placement of catheter:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Guidance for removal of catheter:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Guidance for reposition of catheter:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Guidance for removal of foreign body:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Guidance for placement of port:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Memory &or recall ability in the last 7D:Find:7D:^Patient:Nom:CMS Assessment


name: Memory &or recall ability in the last 7D


name: MDS v3.0 - RAI v1.17.2, OASIS E - Signs and symptoms of delirium (from CAM):-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.16.1 - Staff assessment for mental status:-:RptPeriod:^Patient:-:CMS Assessment


name: Potential indicators of psychosis:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Staff assessment of daily and activity preferences:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Preferences for customary routine and activities:-:RptPeriod:^Patient:-:CMS Assessment


name: Mobility devices normally used during assessment period:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Functional abilities and goals - admission:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Functional abilities and goals - admission


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - admission performance:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - admission performance


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - admission performance during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - admission performance during 3D assessment period


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Functional abilities and goals - discharge:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Functional abilities and goals - discharge


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - discharge performance:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - discharge performance


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge performance during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge performance during 3D assessment period


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - discharge goal:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Self-care - discharge goal


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge goal during 3D assessment period:-:3D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Mobility - discharge goal during 3D assessment period


name: MDS v3.0 - RAI v1.14.1 - Bladder and bowel:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Bladder and bowel


name: Bladder and bowel appliances used:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status


name: MDS v3.0 - RAI v1.17.2 - Active diagnoses - ND:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Active diagnoses


name: Staff assessment for pain:-:RptPeriod:^Patient:-:CMS Assessment


name: Indicators of pain or possible pain:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Other health conditions:-:RptPeriod:^Patient:-:CMS Assessment


name: Shortness of breath:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Signs and symptoms of swallowing disorder:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Weight gain of 5% or more in the last month or gain of 10% or more in last 6Mo:Find:6Mo:^Patient:Ord:CMS Assessment


name: Weight gain of 5% or more in the last month or gain of 10% or more in last 6Mo


name: Percent intake by artificial route:-:RptPeriod:^Patient:-:CMS Assessment


name: Proportion of total calories the resident received through parenteral or tube feeding in the 7D - while not a resident:Find:7D:^Patient:Ord:CMS Assessment


name: Proportion of total calories the resident received through parenteral or tube feeding in the 7D - while not a resident


name: Proportion of total calories the resident received through parenteral or tube feeding in last 7D - while a resident:Find:7D:^Patient:Ord:CMS Assessment


name: Proportion of total calories the resident received through parenteral or tube feeding in last 7D - while a resident


name: Mean fluid intake per day by IV or tube feeding in last 7D - while not a resident:VRat:7D:^Patient:Qn:CMS Assessment


name: Mean fluid intake per day by IV or tube feeding in last 7D - while not a resident


name: Mean fluid intake per day by IV or tube feeding in last 7D - while a resident:VRat:7D:^Patient:Qn:CMS Assessment


name: Mean fluid intake per day by IV or tube feeding in last 7D - while a resident


name: Mean fluid intake per day by IV or tube feeding during entire 7D:VRat:7D:^Patient:Qn:CMS Assessment


name: Mean fluid intake per day by IV or tube feeding during entire 7D


name: Oral &or dental status:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Health conditions:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Health conditions


name: Proportion of total calories the resident received through parenteral or tube feeding during entire 7D:Find:7D:^Patient:Ord:CMS Assessment


name: Proportion of total calories the resident received through parenteral or tube feeding during entire 7D


name: Dental problems during assessment period:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: MDS v3.00 - RAI v1.14.1 - Skin conditions:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.00 - RAI v1.14.1 - Skin conditions


name: Determination of pressure injury risk in last 7D:Find:7D:^Patient:Nom:CMS Assessment


name: Determination of pressure injury risk in last 7D


name: Number of D hypnotic received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D hypnotic received in last 7D or since admission &or reentry if less than 7D


name: Number of D anticoagulant received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D anticoagulant received in last 7D or since admission &or reentry if less than 7D


name: Number of D antibiotic received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D antibiotic received in last 7D or since admission &or reentry if less than 7D


name: Number of D diuretic received in last 7D or since admission &or reentry if less than 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D diuretic received in last 7D or since admission &or reentry if less than 7D


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs


name: MDS v3.0 - RAI v1.17.1, 1.17.2 - Special treatments, procedures, and programs:-:RptPeriod:^Patient:-:CMS Assessment


name: Procedures performed during last 14D - while not a resident:Find:14D:^Patient:Nom:CMS Assessment


name: Procedures performed during last 14D - while not a resident


name: Procedures performed during last 14D - while a resident:Find:14D:^Patient:Nom:CMS Assessment


name: Procedures performed during last 14D - while a resident


name: Speech-language pathology and audiology services:-:RptPeriod:^Patient:-:CMS Assessment


name: Occupational therapy - co-treatment minutes during 7D assessment period:Time:7D:^Patient:Qn:CMS Assessment


name: Occupational therapy - co-treatment minutes during 7D assessment period


name: Speech-language pathology and audiology services - co-treatment minutes during 7D assessment period:Time:7D:^Patient:Qn:CMS Assessment


name: Speech-language pathology and audiology services - co-treatment minutes during 7D assessment period


name: Physical therapy - co-treatment minutes during 7D assessment period:Time:7D:^Patient:Qn:CMS Assessment


name: Physical therapy - co-treatment minutes during 7D assessment period


name: Distinct calendar days of therapy in last 7D:NRat:7D:^Patient:Qn:CMS Assessment


name: Distinct calendar days of therapy in last 7D


name: Resumption of therapy:-:RptPeriod:^Patient:-:CMS Assessment


name: Date therapy regimen resumed:Date:RptPeriod:^Patient:Qn:CMS Assessment


name: Previous rehabilitation therapy regimen (speech, occupational, &or physical therapy) ended, & regimen now resumed at exactly the same level for each discipline:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Restorative nursing programs:-:RptPeriod:^Patient:-:CMS Assessment


name: Number of D of passive range of motion in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of passive range of motion in last 7 calendar D


name: Number of D of active range of motion in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of active range of motion in last 7 calendar D


name: Number of D of splint or brace assistance in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of splint or brace assistance in last 7 calendar D


name: Number of D of training & skill practice in bed mobility in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of training & skill practice in bed mobility in last 7 calendar D


name: Number of D of training & skill practice in transfer in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of training & skill practice in transfer in last 7 calendar D


name: Number of D of training & skill practice in walking in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of training & skill practice in walking in last 7 calendar D


name: Number of D of training & skill practice in dressing or grooming in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of training & skill practice in dressing or grooming in last 7 calendar D


name: Number of D of training & skill practice in eating or swallowing in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of training & skill practice in eating or swallowing in last 7 calendar D


name: Number of D of training & skill practice in amputation or prosthesis care in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of training & skill practice in amputation or prosthesis care in last 7 calendar D


name: Number of D of training & skill practice in communication in last 7 calendar D:NRat:7D:^Patient:Qn:CMS Assessment


name: Number of D of training & skill practice in communication in last 7 calendar D


name: Physical restraints used in bed - bed rail used during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Physical restraints used in bed - trunk restraint used during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Physical restraints used in bed - limb restraint during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Other physical restraints used in bed during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Physical restraints used in chair or out of bed - trunk restraint used during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Physical restraints used in chair or out of bed - limb restraint used during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Physical restraints used in chair or out of bed - chair prevents rising used during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: Other physical restraints used in chair or out of bed used during assessment period:NRat:RptPeriod:^Patient:Ord:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Participation in assessment and goal setting:-:RptPeriod:^Patient:-:CMS Assessment


name: Clinical record documents a request that questions regarding possible return to the community be asked only on comprehensive assessments:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Clinical record documents a request that questions regarding possible return to the community be asked only on comprehensive assessments


name: Resident's preference regarding being asked about returning to the community:-:RptPeriod:^Patient:-:CMS Assessment


name: Resident (or legally authorized representative) wants to be asked about returning to the community on all assessments:Find:RptPeriod:^Patient:Ord:CMS Assessment


name: Resident (or legally authorized representative) wants to be asked about returning to the community on all assessments


name: Information source for preference on return to community queries:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Information source for preference on return to community queries


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NP, NQ:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NP, NQ


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NS, SS:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NS, SS


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NO, NSD, ND, NOD, SP, SO, SSD, SD, SOD, NPE:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NO, NSD, ND, NOD, SP, SO, SSD, SD, SOD, NPE


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NT, ST:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Identification information - NT, ST


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Hearing, speech, and vision - NO, NOD, SO, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Hearing, speech, and vision - NO, NOD, SO, SOD


name: MDS v3.0 - RAI v1.17.2 - Staff assessment for mental status - ND, SD, IPA, OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Behavior - NP, NQ, ND, SD, SP, IPA, OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Functional status - NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Functional status - OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Functional status - NSD, NOD, SSD, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Functional status - NSD, NOD, SSD, SOD


name: MDS v3.0 - RAI v1.17.2 - Functional status - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Bladder and bowel - NP, NQ, NSD, NOD, SP, SSD, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Bladder and bowel - NP, NQ, NSD, NOD, SP, SSD, SOD


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Active diagnoses - NO, SO:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Active diagnoses - NO, SO


name: MDS v3.0 - RAI v1.17.2 - Health conditions - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Health Conditions - NPE:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NO, SO:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NO, SO


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NSD, ND, SSD, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NSD, ND, SSD, SD


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NOD, SP, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Swallowing &or nutritional status - NOD, SP, SOD


name: MDS v3.0 - RAI v1.14.1 - Skin conditions - NO, SO:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Skin conditions - NO, SO


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Skin conditions - NSD, ND, SSD, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Skin conditions - NSD, ND, SSD, SD


name: MDS v3.0 - RAI v1.14.1 - Skin conditions - NOD, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Skin conditions - NOD, SOD


name: MDS v3.0 - RAI v1.17.2 - Skin conditions - NPE:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Medications - OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Medications - NSD, ND, SSD, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Medications - NSD, ND, SSD, SD


name: Staff assessment of resident mood (PHQ-9-OV) - symptom presence in the last 2W:-:2W:^Patient:-:CMS Assessment


name: Staff assessment of resident mood (PHQ-9-OV) - symptom presence in the last 2W


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NP, NQ:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NP, NQ


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NS, SS:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NS, SS


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NO, SO:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NO, SO


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NSD, SSD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Special treatments, procedures, and programs - NSD, SSD


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Participation in assessment and goal setting - NS, NO, SS, SO:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Participation in assessment and goal setting - NS, NO, SS, SO


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Participation in assessment and goal setting - NSD, NOD, SSD, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Participation in assessment and goal setting - NSD, NOD, SSD, SOD


name: MDS v3.0 - RAI v1.17.2 - Participation in assessment and goal setting - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Speech-language pathology and audiology services - ND:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Nursing home PPS (NP) & Nursing home quarterly (NQ) item set


name: MDS v3.0 - RAI v1.17.2 - Urinary toileting program - NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Health conditions - NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Health conditions - NP, NQ, SP


name: MDS v3.0 - RAI v1.17.2 - Other health conditions - NP, NQ, SP:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Hearing, speech, and vision - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed OMRA (NO & SO) item set


name: MDS v3.0 - RAI v1.14.1 - Nursing home OMRA start of therapy and discharge (NSD) & Swing bed OMRA start of therapy and discharge (SSD) item set


name: MDS v3.0 - RAI v1.14.1 - Nursing home discharge (ND) & Swing bed discharge (SD) item set


name: MDS v3.0 - RAI v1.14.1 - Nursing home OMRA-discharge (NOD) & Swing bed OMRA-discharge (SOD) item set


name: MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed OMRA start of therapy (NS & SS) item set


name: MDS v3.0 - RAI v1.14.1 - Nursing home & Swing bed tracking (NT & ST) item set


name: MDS v3.0 - RAI v1.14.1 - Swing bed PPS (SP) item set


name: MDS v3.0 - RAI v1.14.1 - Nursing home part A PPS discharge (NPE) item set


name: MDS v3.0 - RAI v1.14.1 - Bladder and bowel - NS, NO, SS, SO:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1 - Bladder and bowel - NS, NO, SS, SO


name: MDS v3.0 - RAI v1.16.1 - Bladder and bowel - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - self-performance:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - support provided:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Activities of daily living (ADL) assistance - support provided


name: MDS v3.0 - RAI v1.16.1 - Cognitive patterns - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Cognitive patterns - NO, SO:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1 - Cognitive patterns - NO, SO


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Activities of daily living (ADL) assistance - support provided - NSD, NOD, SSD, SOD:-:7D:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Activities of daily living (ADL) assistance - support provided - NSD, NOD, SSD, SOD


name: MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - self-performance - OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Activities of daily living (ADL) assistance - support provided - OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Bathing - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Health conditions - OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Other health conditions - IPA, OSA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Other health conditions - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: Staff assessment of resident mood (PHQ-9-OV) - symptom frequency in the last 2W:-:2W:^Patient:-:CMS Assessment


name: Staff assessment of resident mood (PHQ-9-OV) - symptom frequency in the last 2W


name: MDS v3.0 - RAI v1.17.2 - Current number of unhealed pressure injuries at each stage - IPA:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.17.2 - Physical therapy - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: Plasma cells.monotypic population:Prid:Pt:Bld:Nom:Flow cytometry


name: Length:Len:RptPeriod:Pressure injury.largest stage 3 or 4:Qn:CMS Assessment


name: Width:Len:RptPeriod:Pressure injury.largest stage 3 or 4:Qn:CMS Assessment


name: Tissue type:Type:RptPeriod:Pressure injury.most advanced stage:Nom:CMS Assessment


name: Outcome and assessment information set (OASIS) form - version C2


name: Intravascular systolic goal:Pres:Pt:Arterial system:Qn


name: Intravascular diastolic goal:Pres:Pt:Arterial system:Qn


name: Kansas City Cardiomyopathy Questionnaire - 12 item:-:Pt:^Patient:-:KCCQ-12


name: Transmissible gastroenteritis virus Ab/Negative control:RelRto:Pt:Ser:Qn:IA


name: Transmissible gastroenteritis virus Ab/Negative control


name: Porcine respiratory coronavirus Ab/Negative control:RelRto:Pt:Ser:Qn:IA


name: Porcine respiratory coronavirus Ab/Negative control


name: Porcine epidemic diarrhea virus whole genome:Seq:Pt:Isolate:Nom:Sequencing


name: Lawsonia intracellularis Ab/Negative control:RelRto:Pt:Ser:Qn:IA


name: Lawsonia intracellularis Ab/Negative control


name: Metanephrine, Normetanephrine & Creatinine panel:-:24H:Urine:-


name: I am confident that I can follow through on medical treatments I may need to do at home:Find:Pt:^Patient:Ord:PAM


name: I am confident that I can follow through on medical treatments I may need to do at home


name: Patient Activation Measure - 13:-:Pt:^Patient:-:PAM


name: I am confident I can figure out solutions when new problems arise with my health:Find:Pt:^Patient:Ord:PAM


name: I am confident I can figure out solutions when new problems arise with my health


name: I know how to prevent problems with my health:Find:Pt:^Patient:Ord:PAM


name: I know how to prevent problems with my health


name: I have been able to maintain (keep up with) lifestyle changes, like eating right or exercising:Find:Pt:^Patient:Ord:PAM


name: I have been able to maintain (keep up with) lifestyle changes, like eating right or exercising


name: I know what treatments are available for my health problems:Find:Pt:^Patient:Ord:PAM


name: I know what treatments are available for my health problems


name: Taking an active role in my own health care is the most important thing that affects my health:Find:Pt:^Patient:Ord:PAM


name: I am confident that I can maintain lifestyle changes, like eating right and exercising, even during times of stress:Find:Pt:^Patient:Ord:PAM


name: I am confident that I can maintain lifestyle changes, like eating right and exercising, even during times of stress


name: I am confident that I can tell a doctor concerns I have even when he or she does not ask:Find:Pt:^Patient:Ord:PAM


name: I am confident that I can tell a doctor concerns I have even when he or she does not ask


name: I am confident that I can tell whether I need to go to the doctor or whether I can take care of a health problem myself:Find:Pt:^Patient:Ord:PAM


name: I am confident that I can tell whether I need to go to the doctor or whether I can take care of a health problem myself


name: I know what each of my prescribed medications do:Find:Pt:^Patient:Ord:PAM


name: I know what each of my prescribed medications do


name: I am confident I can help prevent or reduce problems associated with my health:Find:Pt:^Patient:Ord:PAM


name: I am confident I can help prevent or reduce problems associated with my health


name: When all is said and done, I am the person who is responsible for taking care of my health:Find:Pt:^Patient:Ord:PAM


name: I understand my health problems and what causes them:Find:Pt:^Patient:Ord:PAM


name: I understand my health problems and what causes them


name: Patient Activation Measure - 10:-:Pt:^Patient:-:PAM


name: Trichomonas vaginalis & Mycoplasma genitalium DNA panel:-:Pt:XXX:-


name: Trichomonas vaginalis & Mycoplasma genitalium DNA panel


name: Lipoprotein associated phospholipase A2:CCnc:Pt:Ser/Plas:Qn


name: Preliminary testing affected submission for further testing:PrThr:Pt:Specimen:Ord


name: Multisection^WO & W contrast IV:Find:Pt:Head>Salivary gland:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Neck+Chest:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Upper extremity.right>Upper extremity vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Upper extremity.left>Upper extremity vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Upper extremity.bilateral>Upper extremity vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Lower extremity.right>Lower extremity vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Lower extremity.left>Lower extremity vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Lower extremity vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Upper extremity.bilateral>Hand:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Upper extremity.bilateral>Shoulder:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Chest vessels & Abdomen>Abdominal vessels:Doc:CT.angio


name: Multisection^WO & W contrast IV:Find:Pt:Head+Neck:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Foot:Doc:CT


name: Multisection^WO & W contrast IV:Find:Pt:Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:CT


name: Multisection for left ventricular function^W contrast IV:Find:Pt:Chest>Heart:Doc:CT


name: Multisection for left ventricular function


name: Multisection metabolic^W radionuclide IV:Find:Pt:Head>Brain:Doc:PT+CT


name: Multisection^W contrast IV:Find:Pt:Head & Head>Temporal bone:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head & Head>Sinuses:Doc:CT


name: Multisection^WO contrast:Find:Pt:Pelvis & Lower extremity.bilateral>Hip:Doc:CT


name: Multisection^WO & W Contrast IV:Find:Pt:Chest>Heart+Coronary arteries:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Chest vessels & Abdomen>Abdominal vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Chest>Chest vessels & Abdomen>Abdominal vessels & Pelvis>Pelvis vessels:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic:Doc:CT


name: Multisection^WO contrast:Find:Pt:Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar:Doc:CT


name: Multisection^W contrast IV:Find:Pt:Head & Head>Orbit.bilateral:Doc:CT


name: Multisection^WO contrast:Find:Pt:Head & Head>Orbit.bilateral:Doc:CT


name: Multisection^WO contrast:Find:Pt:Head & Head>Maxillofacial region & Neck>Spine.cervical:Doc:CT


name: Multisection^WO contrast:Find:Pt:Head & Head>Sinuses:Doc:CT


name: Guidance 1 level for kyphoplasty:Find:Pt:XXX>Spine vertebra:Doc:{Imaging modality}


name: Guidance 1 or 2 for injection of trigger point:Find:Pt:XXX>Muscle:Doc:{Imaging modality}


name: Guidance 1 or 2 for injection of trigger point


name: Guidance additional for augmentation:Find:Pt:XXX>Spine vertebra:Doc:{Imaging modality}


name: Guidance additional day for infusion of thrombolytic^W thrombolytic via catheter:Find:Pt:XXX>Vessel:Doc:{Imaging modality}


name: Guidance additional day for infusion of thrombolytic


name: Guidance additional for percutaneous mechanical thrombectomy:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance additional for percutaneous mechanical thrombectomy


name: Guidance additional for percutaneous mechanical thrombectomy:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance additional for placement of endovascular device:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance additional for placement of endovascular device


name: Guidance additional for placement of stent:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance additional for placement of stent


name: Guidance additional for placement of wire:Find:Pt:XXX:Doc:{Imaging modality}


name: Guidance additional for placement of wire


name: Guidance additional for vertebroplasty:Find:Pt:XXX>Spine vertebra:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of fluid:Find:Pt:XXX>Joint.intermediate:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of fluid:Find:Pt:XXX>Joint.major:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of fluid:Find:Pt:XXX>Joint.small:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of fluid:Find:Pt:XXX>Joint:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of fluid:Find:Pt:XXX>Bone marrow:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of cyst:Find:Pt:XXX:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of cyst:Find:Pt:XXX>Bone:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of ganglion cyst:Find:Pt:XXX:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of ganglion cyst


name: Guidance for percutaneous aspiration of fluid:Find:Pt:XXX>Lymph node:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Bone:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Bone marrow:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Lymph node:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Soft tissue:Doc:{Imaging modality}


name: Guidance for deep biopsy:Find:Pt:XXX>Bone:Doc:{Imaging modality}


name: Guidance for embolization:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance for embolization:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance for embolization:Find:Pt:XXX>Vessels:Doc:{Imaging modality}


name: Guidance additional day for infusion of thrombolytic^W thrombolytic via chest tube:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance additional level for kyphoplasty:Find:Pt:Chest>Spine.thoracic:Doc:{Imaging modality}


name: Guidance additional level for kyphoplasty


name: Guidance additional for vertebroplasty:Find:Pt:Chest>Spine.thoracic:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Chest>Pleura:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Chest>Lung:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Chest>Mediastinum:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Neck+Chest>Soft tissue:Doc:{Imaging modality}


name: Guidance for check of peritoneovenous shunt:Find:Pt:Chest+Abdomen:Doc:{Imaging modality}


name: Guidance for check of peritoneovenous shunt


name: Guidance for cryoablation:Find:Pt:Chest>Lung:Doc:{Imaging modality}


name: Guidance for drainage+placement of chest tube:Find:Pt:Chest>Pleural space:Doc:{Imaging modality}


name: Guidance for exchange of catheter portion only of central venous catheter with port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for exchange of catheter portion only of central venous catheter with port


name: Guidance for exchange of central venous catheter with port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for exchange of central venous catheter with port


name: Guidance additional level for kyphoplasty:Find:Pt:Abdomen>Spine.lumbar:Doc:{Imaging modality}


name: Guidance additional for placement of stent:Find:Pt:Abdomen+Pelvis>Iliac artery:Doc:{Imaging modality}


name: Guidance additional for percutaneous transluminal angioplasty:Find:Pt:Abdomen+Pelvis>Iliac artery:Doc:{Imaging modality}


name: Guidance additional for percutaneous transluminal angioplasty


name: Guidance additional for vertebroplasty:Find:Pt:Abdomen>Spine.lumbar:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of cyst:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen+Pelvis>Ureter:Doc:{Imaging modality}


name: Guidance for check of tube:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for cholangioscopy+removal of calculus:Find:Pt:Abdomen>Gallbladder:Doc:{Imaging modality}


name: Guidance for cholangioscopy+removal of calculus


name: Guidance for placement of clip^preoperative:Find:Pt:XXX:Doc:{Imaging modality}


name: Guidance for biopsy:Find:Pt:Pelvis>Prostate:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:XXX>Muscle:Doc:{Imaging modality}


name: Guidance for deep drainage+placement of drainage catheter:Find:Pt:Pelvis:Doc:{Imaging modality}


name: Plan of care note:Find:Pt:{Setting}:Doc:Dialysis.interdisciplinary


name: Virus identified:Prid:Pt:Respiratory system specimen.lower:Nom:Culture


name: Guidance for cholangioscopy:Find:Pt:Abdomen>Gallbladder:Doc:{Imaging modality}


name: Guidance for cholecystostomy:Find:Pt:Abdomen>Gallbladder:Doc:{Imaging modality}


name: Guidance for conversion of gastrostomy tube to gastrojejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:{Imaging modality}


name: Guidance for conversion of gastrostomy tube to gastrojejunostomy tube


name: Guidance for cryoablation:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for cryoablation:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for dilation of stricture:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for exchange of gastrostomy tube:Find:Pt:Abdomen>Stomach:Doc:{Imaging modality}


name: Guidance for exchange of gastrostomy tube


name: Guidance for exchange of jejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:{Imaging modality}


name: Guidance for exchange of jejunostomy tube


name: Guidance for percutaneous exchange of nephrostomy tube:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Pancreas:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen:Doc:{Imaging modality}


name: Guidance for placement of fiducial marker:Find:Pt:Abdomen:Doc:{Imaging modality}


name: Guidance for placement of fiducial marker


name: Guidance for radiofrequency ablation:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for removal of calculus:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for injection of contrast:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for nerve block:Find:Pt:Abdomen>Celiac plexus:Doc:{Imaging modality}


name: Guidance for removal of gastrojejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:{Imaging modality}


name: Guidance for removal of gastrojejunostomy tube


name: Guidance for placement of gastrojejunostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:{Imaging modality}


name: Guidance for placement of gastrojejunostomy tube


name: Guidance for placement of gastrostomy tube:Find:Pt:Abdomen>Gastrointestinal tract.upper:Doc:{Imaging modality}


name: Guidance for placement of gastrostomy tube


name: Guidance for percutaneous placement of nephrostomy tube:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for percutaneous placement of nephrostomy tube


name: Guidance for transjugular biopsy:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for transjugular biopsy+venography:Find:Pt:Abdomen>Kidney:Doc:{Imaging modality}


name: Guidance for transjugular biopsy+venography


name: Guidance for hemodynamic evaluation:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for microwave ablation:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for radiofrequency ablation:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for transjugular placement of transjugular intrahepatic portosystemic shunt:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for transjugular revision of transjugular intrahepatic portosystemic shunt:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for transjugular revision of transjugular intrahepatic portosystemic shunt


name: Guidance for transhepatic revision of tube:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for transhepatic revision of tube


name: Guidance for transjugular biopsy:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for transjugular biopsy+hemodynamic evaluation:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for transjugular biopsy+hemodynamic evaluation


name: Guidance for transjugular biopsy+venography:Find:Pt:Abdomen>Liver:Doc:{Imaging modality}


name: Guidance for percutaneous drainage+placement of drainage catheter:Find:Pt:Abdomen:Doc:{Imaging modality}


name: Guidance for paracentesis+insertion of tube:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Guidance for paracentesis+insertion of tube


name: Guidance for paracentesis:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Guidance for removal of port:Find:Pt:Abdomen>Peritoneum:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Abdomen>Renal artery:Doc:{Imaging modality}


name: Guidance for puncture:Find:Pt:Abdomen>Spine.lumbar:Doc:{Imaging modality}


name: Guidance for kyphoplasty:Find:Pt:Abdomen>Spine.lumbar:Doc:{Imaging modality}


name: Guidance for myelography:Find:Pt:Abdomen>Spine.lumbar:Doc:{Imaging modality}


name: Group counseling note:Find:Pt:{Setting}:Doc:Addiction medicine


name: Risk assessment and screening note:Find:Pt:{Setting}:Doc:Addiction medicine


name: History and physical note:Find:Pt:{Setting}:Doc:Addiction medicine


name: Initial evaluation note:Find:Pt:{Setting}:Doc:Addiction medicine


name: Escherichia coli enterotoxigenic heat-labile toxin DNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli enterotoxigenic sta gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli enterotoxigenic stb gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Porcine circovirus type 1 DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Escherichia coli Stx2e toxin stx2e gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Porcine hemagglutinating encephalomyelitis virus RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Cystatin C & Glomerular filtration rate by Cystatin C-based formula panel:-:Pt:Ser/Plas:-


name: Cystatin C & Glomerular filtration rate by Cystatin C-based formula panel


name: Herpes simplex virus 1 & 2 DNA panel:-:Pt:XXX:Ord:Probe.amp.tar


name: Mycophenolate & mycophenolate glucuronide panel:-:Pt:Ser/Plas:Qn


name: Mycophenolate & mycophenolate glucuronide panel


name: Haloperidol & haloperidol.reduced panel:-:Pt:Ser/Plas:Qn


name: Haloperidol and reduced haloperidol panel


name: Neutrophil cytoplasmic Ab.IgG & Saccharomyces cerevisiae Ab.IgA & IgG:-:Pt:Ser:-


name: IgA & IgA subclass 1 & IgA subclass 2 panel:-:Pt:Ser/Plas:Qn


name: immunoglobulin A & immunoglobulin A subclass 1 & immunoglobulin A subclass 2 panel


name: Guidance for vertebroplasty:Find:Pt:Abdomen>Spine.lumbar:Doc:{Imaging modality}


name: Guidance for placement of venous filter:Find:Pt:Abdomen>Vena cava.inferior:Doc:{Imaging modality}


name: Guidance for nerve block:Find:Pt:XXX>Nerve root:Doc:{Imaging modality}


name: Guidance for percutaneous exchange of nephroureteral stent:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:{Imaging modality}


name: Guidance for percutaneous exchange of nephroureteral stent


name: Guidance for transurethral removal of nephroureteral stent:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:{Imaging modality}


name: Guidance for transurethral removal of nephroureteral stent


name: Guidance for percutaneous placement of nephroureteral stent:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:{Imaging modality}


name: Guidance for percutaneous removal of nephroureteral stent:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:{Imaging modality}


name: Guidance for percutaneous removal of nephroureteral stent


name: Clostridium perfringens cpb2 gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Clostridium perfringens cpe gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Clostridium perfringens etx gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Guidance for transhepatic removal of catheter:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for transhepatic removal of catheter


name: Guidance for transhepatic placement of catheter:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for transhepatic placement of catheter


name: Guidance for transhepatic exchange of catheter:Find:Pt:Abdomen>Biliary ducts:Doc:{Imaging modality}


name: Guidance for transhepatic exchange of catheter


name: Salmonella sp Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: West Nile virus RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Bacteria identified:Prid:Pt:Plr fld:Nom:Anaerobic culture


name: Bacteria identified:Prid:Pt:Synv fld:Nom:Anaerobic culture


name: Borrelia sp identified:Prid:Pt:CSF:Nom:Organism specific culture


name: Borrelia sp identified:Prid:Pt:Tiss:Nom:Organism specific culture


name: Clostridium botulinum:PrThr:Pt:Stool:Ord:Organism specific culture


name: Guidance for removal of venous filter:Find:Pt:Abdomen>Vena cava.inferior:Doc:{Imaging modality}


name: Guidance for reposition of venous filter:Find:Pt:Abdomen>Vena cava.inferior:Doc:{Imaging modality}


name: Guidance for reposition of venous filter


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Abdomen>Visceral artery:Doc:{Imaging modality}


name: Guidance for placement of stent:Find:Pt:Abdomen>Visceral artery:Doc:{Imaging modality}


name: Guidance for placement of peritoneovenous shunt:Find:Pt:Chest+Abdomen:Doc:{Imaging modality}


name: Guidance for placement of peritoneovenous shunt


name: Guidance for removal of peritoneovenous shunt:Find:Pt:Chest+Abdomen:Doc:{Imaging modality}


name: Guidance for removal of peritoneovenous shunt


name: Guidance for revision of peritoneovenous shunt:Find:Pt:Chest+Abdomen:Doc:{Imaging modality}


name: Guidance for revision of peritoneovenous shunt


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Chest>Aorta.thoracic & Abdomen>Aorta.abdominal:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Chest>Brachiocephalic artery:Doc:{Imaging modality}


name: Guidance initial day for infusion of thrombolytic^W thrombolytic via chest tube:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance initial day for infusion of thrombolytic


name: Guidance for infusion of thrombolytic^W thrombolytic via central venous catheter:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for injection of central venous catheter:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for injection of central venous catheter


name: Guidance for reposition of central venous catheter:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for placement of central venous catheter with port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for placement of central venous catheter with port


name: Guidance for removal of central venous catheter with port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for removal of central venous catheter with port


name: Guidance for repair of central venous catheter with port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for repair of central venous catheter with port


name: Guidance for placement of Swan-Ganz catheter:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for placement of Swan-Ganz catheter


name: Guidance for thoracentesis+insertion of tube:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for thoracentesis+insertion of tube


name: Guidance for thoracentesis:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for exchange of tunneled central venous catheter without port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for exchange of tunneled central venous catheter without port


name: Guidance for placement of tunneled central venous catheter without port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for placement of tunneled central venous catheter without port


name: Guidance for removal of tunneled central venous catheter without port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for removal of tunneled central venous catheter without port


name: Guidance for repair of non-tunneled central venous catheter without port:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for repair of non-tunneled central venous catheter without port


name: Guidance for placement of chest tube:Find:Pt:Chest>Pleural space:Doc:{Imaging modality}


name: Guidance for pericardiocentesis:Find:Pt:Chest>Heart:Doc:{Imaging modality}


name: Guidance for placement of fiducial marker:Find:Pt:Chest>Lung:Doc:{Imaging modality}


name: Guidance for microwave ablation:Find:Pt:Chest>Lung:Doc:{Imaging modality}


name: Guidance for radiofrequency ablation:Find:Pt:Chest>Lung:Doc:{Imaging modality}


name: Guidance for placement of tunneled catheter:Find:Pt:Chest>Pleura:Doc:{Imaging modality}


name: Guidance for placement of tunneled catheter


name: Guidance for kyphoplasty:Find:Pt:Chest>Spine.thoracic:Doc:{Imaging modality}


name: Guidance for myelography:Find:Pt:Chest>Spine.thoracic:Doc:{Imaging modality}


name: Guidance for vertebroplasty:Find:Pt:Chest>Spine.thoracic:Doc:{Imaging modality}


name: Guidance for nerve block:Find:Pt:Chest>Spine.thoracic intercostal nerve:Doc:{Imaging modality}


name: Guidance for removal of venous filter:Find:Pt:Chest>Vena cava.superior:Doc:{Imaging modality}


name: Guidance for reposition of venous filter:Find:Pt:Chest>Vena cava.superior:Doc:{Imaging modality}


name: Guidance for placement of venous filter:Find:Pt:Chest>Vena cava.superior:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Lower extremity>Lower leg:Doc:{Imaging modality}


name: Guidance for laser ablation:Find:Pt:Extremity>Extremity vein:Doc:{Imaging modality}


name: Guidance GE 21 for stab phlebectomy:Find:Pt:Extremity>Extremity vein:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:Lower extremity>Ankle:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Lower extremity.unilateral>Femoral artery+Popliteal artery:Doc:{Imaging modality}


name: Guidance for placement of stent:Find:Pt:Lower extremity.unilateral>Femoral artery+Popliteal artery:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:Lower extremity>Hip:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration of fluid:Find:Pt:Lower extremity>Knee:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:Lower extremity>Knee:Doc:{Imaging modality}


name: Guidance additional for laser ablation:Find:Pt:Extremity>Extremity vein:Doc:{Imaging modality}


name: Guidance additional for percutaneous transluminal angioplasty:Find:Pt:Lower extremity>Lower leg:Doc:{Imaging modality}


name: Guidance additional for placement of stent:Find:Pt:Lower extremity>Lower leg vessel:Doc:{Imaging modality}


name: Guidance for placement of central venous catheter with port:Find:Pt:Upper extremity:Doc:{Imaging modality}


name: Guidance for exchange of central venous catheter with port:Find:Pt:Upper extremity:Doc:{Imaging modality}


name: Guidance for exchange of peripherally-inserted central venous catheter:Find:Pt:Upper extremity:Doc:{Imaging modality}


name: Guidance for exchange of peripherally-inserted central venous catheter


name: Guidance for placement of peripherally-inserted central venous catheter:Find:Pt:Upper extremity:Doc:{Imaging modality}


name: Guidance for embolization:Find:Pt:Upper extremity>Brachial artery:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:Upper extremity>Shoulder:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:Upper extremity>Wrist:Doc:{Imaging modality}


name: Guidance for exchange of chest tube:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:Abdomen+Pelvis>Iliac artery:Doc:{Imaging modality}


name: Guidance for placement of stent:Find:Pt:Abdomen+Pelvis>Iliac artery:Doc:{Imaging modality}


name: Guidance for exchange of ureterostomy through ileal conduit:Find:Pt:Abdomen+Pelvis>Ureter:Doc:{Imaging modality}


name: Guidance for exchange of ureterostomy through ileal conduit


name: Guidance therapeutic for puncture+drainage:Find:Pt:Neck>Spine.cervical:Doc:{Imaging modality}


name: Guidance therapeutic for puncture+drainage


name: Guidance diagnostic for puncture:Find:Pt:Neck>Spine.cervical:Doc:{Imaging modality}


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:Neck>Thyroid gland:Doc:{Imaging modality}


name: Guidance for percutaneous biopsy.core needle:Find:Pt:Neck>Thyroid gland:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:XXX>Tendon:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:Head>Temporomandibular joint:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:XXX>Spine facet joint:Doc:{Imaging modality}


name: Guidance for injection:Find:Pt:XXX>Spine epidural space:Doc:{Imaging modality}


name: Guidance for placement of endovascular device:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance for placement of endovascular device


name: Guidance secondary for percutaneous mechanical thrombectomy:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance secondary for percutaneous mechanical thrombectomy


name: Guidance for placement of endograft:Find:Pt:Abdomen+Pelvis>Iliac artery:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance initial for percutaneous mechanical thrombectomy:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance initial for percutaneous mechanical thrombectomy


name: Guidance for ligation:Find:Pt:XXX>Lymphatic vessel:Doc:{Imaging modality}


name: Guidance for radiofrequency ablation:Find:Pt:XXX>Bone:Doc:{Imaging modality}


name: Guidance for radiofrequency ablation:Find:Pt:Chest>Pleura:Doc:{Imaging modality}


name: Guidance final day for infusion of thrombolytic^W thrombolytic via catheter:Find:Pt:XXX>Vessel:Doc:{Imaging modality}


name: Guidance final day for infusion of thrombolytic


name: Guidance for percutaneous aspiration.fine needle:Find:Pt:XXX:Doc:{Imaging modality}


name: Guidance for dilation:Find:Pt:Pelvis>Fallopian tube:Doc:{Imaging modality}


name: Guidance for embolization:Find:Pt:Pelvis>Uterine artery:Doc:{Imaging modality}


name: Guidance GE 3 for injection of trigger point:Find:Pt:XXX>Muscle:Doc:{Imaging modality}


name: Guidance GE 3 for injection of trigger point


name: Guidance for percutaneous transluminal angioplasty of arterial anastomosis:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty of arterial anastomosis


name: Guidance for percutaneous sympathectomy:Find:Pt:XXX>Nerve:Doc:{Imaging modality}


name: Guidance initial day for infusion of thrombolytic^W thrombolytic via catheter:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance initial for percutaneous mechanical thrombectomy:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance initial day for infusion of thrombolytic^W thrombolytic via catheter:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance for infusion of non-thrombolytic:Find:Pt:XXX>Vessel:Doc:{Imaging modality}


name: Guidance for infusion of non-thrombolytic


name: Guidance for retrieval of foreign body:Find:Pt:XXX>Vessel:Doc:{Imaging modality}


name: Guidance for placement of stent:Find:Pt:XXX>Artery:Doc:{Imaging modality}


name: Guidance for treatment:Find:Pt:XXX>AV fistula:Doc:{Imaging modality}


name: Guidance for venous sampling:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance for transurethral exchange of nephroureteral stent:Find:Pt:Abdomen>Kidney & Abdomen+Pelvis>Ureter & Pelvis>Urinary bladder:Doc:{Imaging modality}


name: Guidance for transurethral exchange of nephroureteral stent


name: Guidance for exchange of non-tunneled central venous catheter:Find:Pt:Chest:Doc:{Imaging modality}


name: Guidance for exchange of non-tunneled central venous catheter


name: Guidance for nerve block:Find:Pt:XXX>Peripheral nerve:Doc:{Imaging modality}


name: Care Area Assessment (CAA) Summary:-:RptPeriod:^Patient:-:CMS Assessment


name: Items from the most recent prior OBRA or scheduled PPS Assessment:-:RptPeriod:^Patient:-:CMS Assessment


name: Correction attestation section:-:RptPeriod:^Patient:-:CMS Assessment


name: Care Area Assessment (CAA) and Care Planning:-:RptPeriod:^Patient:-:CMS Assessment


name: Care Area Assessment (CAA) results:-:RptPeriod:^Patient:-:CMS Assessment


name: Care area triggered:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: Triggered care area included in care plan:Find:RptPeriod:^Patient:Nom:CMS Assessment


name: LCDS v4.00 - Special treatments, procedures, and programs - discharge:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Special treatments, procedures, and programs - discharge


name: LCDS v4.00 - Hearing, speech, and vision:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Hearing, speech, and vision


name: Date on existing record to be modified or inactivated:-:RptPeriod:^Patient:-:CMS Assessment


name: Date on existing record to be modified or inactivated


name: Reasons for modification:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: RN asessment coordinator attestation of completion:-:RptPeriod:^Patient:-:CMS Assessment


name: RN asessment coordinator attestation of completion


name: Attesting individual first name:Pn:RptPeriod:Provider:Nom:CMS Assessment


name: Attesting individual last name:Pn:RptPeriod:Provider:Nom:CMS Assessment


name: Attesting individual title:Type:RptPeriod:Provider:Nom:CMS Assessment


name: Reasons for inactivation:Type:RptPeriod:^Patient:Nom:CMS Assessment


name: Type of assessment on existing record to be modified or inactivated:-:RptPeriod:^Patient:-:CMS Assessment


name: Type of assessment on existing record to be modified or inactivated


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Assessment administration - NS, NO, NSD, NOD, SP, SS, SO, SSD, SOD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Assessment administration - NS, NO, NSD, NOD, SP, SS, SO, SSD, SOD


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Assessment administration - ND, SD:-:RptPeriod:^Patient:-:CMS Assessment


name: MDS v3.0 - RAI v1.14.1, v1.15.1, v1.16.1 - Assessment administration - ND, SD


name: LCDS v4.00 - Special treatments, procedures, and programs - admission:-:RptPeriod:^Patient:-:CMS Assessment


name: LCDS v4.00 - Special treatments, procedures, and programs - admission


name: Plan of care note:Find:Pt:{Setting}:Doc:Dialysis


name: Postoperative evaluation and management note:Find:Pt:{Setting}:Doc:Mental health


name: Preoperative evaluation and management note:Find:Pt:{Setting}:Doc:Mental health


name: Microscopic observation:PrThr:Pt:XXX:Ord:Auramine fluorochrome stain


name: Note:Find:Pt:Custodial care facility:Doc:Addiction medicine


name: Medication management note:Find:Pt:{Setting}:Doc:Addiction medicine


name: Admission evaluation note:Find:Pt:{Setting}:Doc:Addiction medicine


name: Plan of care note:Find:Pt:{Setting}:Doc:Addiction medicine


name: Discharge summary note:Find:Pt:{Setting}:Doc:Addiction medicine


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG & IgM panel:-:Pt:Ser:-:Line blot


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG & IgM panel


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG:PrThr:Pt:Ser:Ord:Line blot


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG band pattern:Imp:Pt:Ser:Nom:Line blot


name: Borrelia afzelii+burgdorferi+garinii Ab.IgG band pattern


name: Borrelia afzelii+burgdorferi+garinii Ab.IgM:PrThr:Pt:Ser:Ord:Line blot


name: Borrelia afzelii+burgdorferi+garinii Ab.IgM band pattern:Imp:Pt:Ser:Nom:Line blot


name: Borrelia afzelii+burgdorferi+garinii Ab.IgM band pattern


name: Multisection^W contrast IV:Find:Pt:Abdomen>Abdominal veins & Pelvis>Pelvis veins & Lower extremity.bilateral>Lower extremity veins:Doc:CT.angio


name: Multisection^W contrast IV:Find:Pt:Lower extremity.bilateral>Lower extremity veins:Doc:CT.angio


name: Relationship to patient's mother:Type:Pt:^Contact:Nom


name: Signature for Social Security Number request:Pn:Pt:^Guardian or legally authorized representative:Nom


name: Signature for Social Security Number request


name: Cigarettes smoked per D^1st trimester:NRat:Pt:^Mother:Qn


name: Cigarettes smoked per D^2nd trimester:NRat:Pt:^Mother:Qn


name: Highest level of education:Hx:Pt:^Father:Ord


name: Married at any time during pregnancy:Find:Pt:^Mother:Ord


name: Paternity acknowledgment form signed:Find:Pt:^Father:Ord


name: Clostridium perfringens cpa gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Guidance for embolization for tumor or ischemia or infarction:Find:Pt:XXX>Vessel:Doc:{Imaging modality}


name: guidance for embolization of tumor or ischemia or infarction


name: Guidance for percutaneous transluminal angioplasty for dialysis:Find:Pt:XXX>Vein:Doc:{Imaging modality}


name: Guidance for percutaneous transluminal angioplasty for dialysis


name: Clostridium perfringens iota toxin DNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Encephalomyocarditis virus:PrThr:Pt:Tiss:Ord:Organism specific culture


name: Escherichia coli eaeA gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli enteroaggregative astA gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Porcine circovirus type 2:PrThr:Pt:XXX:Ord:Organism specific culture


name: Porcine circovirus type 2 Ab:Titr:Pt:Ser:SemiQn:IA


name: Porcine circovirus type 2 Ab.IgG:Titr:Pt:Ser:SemiQn:IA


name: Porcine circovirus type 2 Ab.IgG+IgM:Titr:Pt:Ser:SemiQn:IF


name: Porcine circovirus type 2 Ab.IgG+IgM:PrThr:Pt:Ser:Ord:IF


name: Porcine circovirus type 2 Ab.IgG/Positive control:RelRto:Pt:Ser:Qn:IA


name: Porcine circovirus type 2 Ab.IgG/Positive control


name: Porcine Circovirus type 2 Ab.Neut:Titr:Pt:Ser:SemiQn:Neut


name: Porcine circovirus type 2 Ab/Negative control:RelRto:Pt:Ser:Qn:IA


name: Porcine circovirus type 2 Ab/Negative control


name: Porcine circovirus type 2 Ag:PrThr:Pt:Tiss:Ord:Immune stain


name: Porcine circovirus type 2 DNA:NCnc:Pt:XXX:Qn:Probe.amp.tar


name: Porcine circovirus type 2 DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Porcine circovirus type 2 DNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Porcine circovirus type 2 RFLP pattern:Type:Pt:Isolate:Nom:RFLP


name: Porcine circovirus type 2 strain identified:Type:Pt:Isolate:Nom:Sequencing


name: Porcine circovirus type 2a DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Porcine circovirus type 2b DNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Pseudorabies virus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Pseudorabies virus glycoprotein 1 Ab/Negative control:RelRto:Pt:Ser:Qn:IA


name: Pseudorabies virus glycoprotein 1 Ab/Negative control


name: Pseudorabies virus glycoprotein B Ab/Negative control:RelRto:Pt:Ser:Qn:IA


name: Pseudorabies virus glycoprotein B Ab/Negative control


name: Senecavirus A:PrThr:Pt:XXX:Ord:Organism specific culture


name: Senecavirus A Ab.IgG/Positive control:RelRto:Pt:Ser:Qn:IA


name: Senecavirus A whole genome:Seq:Pt:Isolate:Nom:Sequencing


name: A. pleuropneumoniae IgG/Positive control IA [Relative ratio]


name: Actinobacillus pleuropneumoniae Ab.IgG/Positive control


name: Actinobacillus pleuropneumoniae Ab/Positive control:RelRto:Pt:Ser/Plas:Qn:IA


name: Actinobacillus pleuropneumoniae Ab/Positive control


name: Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotype 10 Ab/Positive control


name: Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotype 12 Ab/Positive control


name: Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotype 2 Ab/Positive control


name: Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotype 5 Ab/Positive control


name: Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 3+6+8 Ab/Positive control


name: Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 4+5+7 Ab/Positive control


name: Toxoplasma gondii Ab/Negative control:RelRto:Pt:Ser/Plas:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 1+2+9+11 Ab/Positive control


name: Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 3+6+8+15 Ab/Positive control


name: Haemophilus parasuis Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Haemophilus parasuis Ab/Positive control


name: Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 4+7 Ab/Positive control


name: Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 1+9+11 Ab/Positive control


name: Erysipelothrix rhusiopathiae Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Erysipelothrix rhusiopathiae Ab/Positive control


name: Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control:RelRto:Pt:Ser:Qn:IA


name: Actinobacillus pleuropneumoniae serotypes 10+12 Ab/Positive control


name: Lawsonia intracellularis VNTR pattern:Type:Pt:XXX:Nom:Molgen


name: Escherichia coli fasA gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli fedF gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli FimF41a gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli K88 DNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli K99 DNA:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli paa gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli Stx1 toxin stx1 gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Escherichia coli Stx2 toxin stx2 gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Tubular extraction rate/1.73 sq M:ArVRat:Pt:Ser/Bld:Qn:Isotopic


name: Porcine parainfluenza virus 1 HN gene:Seq:Pt:Isolate:Nom:Sequencing


name: Porcine parainfluenza virus 1 F gene:Seq:Pt:Isolate:Nom:Sequencing


name: Porcine parainfluenza virus 1 RNA:ThreshNum:Pt:XXX:Qn:Probe.amp.tar


name: Porcine parainfluenza virus 1 RNA:PrThr:Pt:XXX:Ord:Probe.amp.tar


name: Porcine sapelovirus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Clostridium perfringens cpb gene:PrThr:Pt:Isolate:Ord:Probe.amp.tar


name: Porcine teschovirus:PrThr:Pt:XXX:Ord:Organism specific culture


name: Brachyspira sp Ag:PrThr:Pt:Tiss:Ord:Immune stain